HOME >> MEDICINE >> NEWS
Effective government/industry collaboration bolsters flu vaccine supply

When faced with an urgent public health need, the federal government, vaccine manufacturers and university-based researchers can work together quickly and effectively to come up with solutions, as demonstrated in the successful clinical trial of the influenza vaccine Fluarix. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), working closely with the Food and Drug Administration (FDA), sponsored the clinical trial that demonstrated the vaccine's safety and ability to generate an immune response and ultimately led to its expedited approval by FDA in August 2005. Fluarix is the first vaccine to receive FDA approval under the agency's accelerated approval regulations.

Details of the Fluarix clinical study are discussed in the November/December 2005 issue of Human Vaccines, available online December 22.

Clinical testing of the seasonal influenza vaccine Fluarix began in December 2004 as an effort to augment the future U.S. flu vaccine supply, which was experiencing an unexpected, significant shortage. Fluarix, which is manufactured by GlaxoSmithKline Biologicals of Rixensart, Belgium, had been approved in 1998 for use in other countries but had never been tested or licensed for use in the United States.

The vaccine was evaluated in a clinical trial involving nearly 1,000 healthy adults at four sites nationwide. Clinical evaluation of the candidate vaccine was performed under an FDA-reviewed "investigational new drug" application, in which potential study volunteers are fully informed about potential risks and benefits and must provide their informed consent before receiving the investigational product. The clinical trial was rapidly initiated and reached capacity enrollment within five days of its launch in December 2004.

"The Fluarix study is an excellent example of what government and industry can accomplish in a short timeframe when faced with a serious public health nee
'"/>

Contact: Kathy Stover
kstover@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
22-Dec-2005


Page: 1 2 3

Related medicine news :

1. Effectiveness of first renin inhibitor drug for treating hypertension is limited
2. Effectiveness of over-the-counter decongestant questioned in new study
3. Effective medical response reduced deaths of critically injured after London bombings
4. Effective HIV control may depend on viral protein targeted by immune cells
5. Effective treatments for panic disorder not reaching patients
6. Effective alcohol dependence treatments defined
7. Effective treatment of a mothers depression reduces risk of psychiatric disorders in her children
8. Effective hospital patient handoffs require better training for physicians
9. Acrux and Oreganon further expand their collaboration
10. Asia-European collaboration addresses water management in Indonesia
11. Penn leads $98 million translational medicine collaboration

Post Your Comments:
(Date:4/1/2015)... BMA Management, a leader in assisted ... name to Gardant Management Solutions this spring. , “The ... direction of our company and mirrors the optimistic, forward-looking ... potential we see,” said Rod Burkett, President and CEO ... place, the company remains committed to providing a dignified, ...
(Date:4/1/2015)... Awareness Month , The National Council on Alcoholism and ... Month every April since 1987. Its purpose is ... issues. During the month of April, NCADD encourages ... For the Health of It: Early Education on Alcoholism ... Month. During April, focus is on the issues ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 This year for ... the Oral Cancer Foundation for an Open House to offer ... 9 a.m. to 4 p.m. An appointment is required and ... dental office at 212-689-0024. In addition, Herald Square Dental ... during the entire month of April at the reduced cost ...
(Date:4/1/2015)... Bird B Gone, the leader in ... now offers a complete line of Bird Netting ... netting products quickly, safely and efficiently. , Having the ... bird netting installation. It’s important to determine exactly what ... a project. This includes deciding whether to use all ...
(Date:4/1/2015)... 01, 2015 After a particularly harsh winter, ... potholes can lead to costly damage, so Amica Insurance ... is sharing the following suggestions from AAA: , ... and be inflated to the manufacturer’s recommended levels. , ... excessive vibration and uneven tire wear can be signs of ...
Breaking Medicine News(10 mins):Health News:Narconon Arrowhead Releases Guide to Handling Alcoholism in the Family for Alcohol Awareness Month 2Health News:Narconon Arrowhead Releases Guide to Handling Alcoholism in the Family for Alcohol Awareness Month 3Health News:Herald Square Dental Celebrates Oral Cancer Awareness Month 2Health News:Bird B Gone Now Carries Complete Bird Netting Hardware 2Health News:Bird B Gone Now Carries Complete Bird Netting Hardware 3Health News:Prepare for potholes with 7 tips from Amica Insurance 2
(Date:4/1/2015)... 2015  Diplomat Pharmacy, Inc. (NYSE: DPLO ), ... LLC, a highly specialized pharmacy and infusion services company ... chronic diseases based in Cincinnati, Ohio ... resources and capabilities will make Diplomat one of the ... BioRx are dedicated to personalized medication therapies for patients ...
(Date:4/1/2015)... Quebec , April 1, 2015 Salix ... "), a wholly owned subsidiary of Valeant Pharmaceuticals International, ... it today provided a Notice of Fundamental Changes, Make-Whole ... Notice of Execution of Supplemental Indenture and Offer to ... 1.5% Convertible Senior Notes due 2019 (the " Notes ...
(Date:4/1/2015)... MOUNTAIN VIEW, Calif. , April 1, ... ) announces that it has signed a definitive ... device company that develops, manufactures and sells minimally ... drainage of targeted areas within the gastrointestinal tract. ... The Xlumena portfolio includes the ...
Breaking Medicine Technology:Diplomat Completes Acquisition of BioRx 2Diplomat Completes Acquisition of BioRx 3Diplomat Completes Acquisition of BioRx 4Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 2Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 3Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 4Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 5Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 6Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 7Boston Scientific Agrees to Acquire Xlumena 2Boston Scientific Agrees to Acquire Xlumena 3Boston Scientific Agrees to Acquire Xlumena 4Boston Scientific Agrees to Acquire Xlumena 5
Cached News: